Treatment of Parkinson’s disease: CHMP has adopted positive opinion for Xadago
The Committee for Medicinal Products for Human Use ( CHMP ) has adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Xadago, 50 mg and 100 mg, f ...
read article